Healthcare
Bill Gates-backed biotech in diagnostic push
Bill Gates-backed biotech in diagnostic push
PHASE Scientific's product portfolio has expanded to include major infectious diseases such as hepatitis and influenza.
Prudential ties up with telemedicine firm MyDoc to launch digital health app
Pulse will provide health tools and consultations for 11 markets in Asia.
Hong Kong medical costs up 9.3% in 2018
The situation isn't any easier for Singapore where costs grew 10%.
Clearbridge Health expands Hong Kong presence with 1,500 sqft clinic
The new clinic features a dedicated space to hold educational health talks for medical tourist agents and patients.
Viva Biotech Holdings raises US$194m in Hong Kong's hottest biotech float
The drug discovery platform attracted retail orders for about 107 times the shares initially available.
Hong Kong's Voluntary Health Insurance Scheme goes live
Features include coverage extended to unknown pre-existing conditions and no limitations on ‘lifetime benefit'.
Government splashes out $16.1b to improve public hospitals
Approximately $700m will go to doctors, nurses and the Hospital Authority’s supporting staff.
Government injects $10b to set up public healthcare stabilisation fund
The Hong Kong Genome Institute will also be established to promote the clinical application research on genomic medicine.
Healthcare spending may double to $315b by 2033
Hospital-based care accounted for total health expenditure of $75.1b in 2018.
A third of Hong Kong workers go through mental health problems during employment
The impact is largely seen in junior employees who have just jumpstarted on their careers.
Hong Kong rolls out district-based clinics as overcrowding intensifies
The first clinic will be located in Kwai Tsing.
Take an exclusive peek into Hong Kong Hospital Authority's daring big data push
A streamlined health app framework will soon be launched.
Hong Kong clinics brace for heated Chinese infant vaccine demand
The moves come after a Mainland biotech firm falsified data for its shots.
Mainland-based Ascletis Pharma launches IPO in Hong Kong's first pre-profit biotech listing
The firm is selling 224.1 million shares at $12 to $16 apiece.
Hong Kong's sickly public healthcare system reaches breaking point
Despite accounting for 90% of the city’s patients, public hospitals only employ 40% of the SAR’s doctors.
Chinese medical tourists are exhausting local HPV cancer drug supply
An estimated 2m Chinese have come to Hong Kong to receive the shot in past two years.
Public healthcare system thrives amidst staggering surplus
Recurrent expenditure on healthcare grew by an average of 7% over the past decade.
Read Here
Advertise
Sign Up
Commentary
Progressive rating system to impact mid-to-luxury residential properties in Hong Kong
Hong Kong universities drive market shift: strategic acquisitions for student housing
Innovation at a Crossroads: Hong Kong's Needed Tech Transformation